Idaho Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 8 (57% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 1,903
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 30.23%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 485
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 21.99%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 63.43% 69.48%
White, Hispanic/Latino Patients 9.56% 7.01%
Black/African American, Non-Hispanic/Latino Patients 1.42% 1.03%
Black/African American, Hispanic/Latino Patients 0.05% 0.00%
Asian Patients3 0.58% 0.21%
American Indian/Alaska Native Patients3 12.61% 8.66%
Native Hawaiian/Other Pacific Islander Patients3 0.16% 0.21%
Patients with More than one race3 1.31% 0.62%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.79% 1.86%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.16% 1.44%
Unreported/Refused to Report Race and Ethnicity 7.93% 9.48%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 494
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 29.28%
COVID-19 Immunization Series Completed 410
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 36.90%
COVID-19 Immunization Series Additional 362
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 7.09%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 57.69% 51.71% 75.97%
White, Hispanic/Latino Patients 12.15% 13.90% 3.04%
Black/African American, Non-Hispanic/Latino Patients 2.83% 2.93% 0.55%
Black/African American, Hispanic/Latino Patients 0.40% 0.24% 0.00%
Asian Patients3 0.61% 1.22% 0.55%
American Indian/Alaska Native Patients3 1.42% 2.93% 1.38%
Native Hawaiian/Other Pacific Islander Patients3 0.20% 0.49% 0.00%
Patients with More than one race3 1.62% 3.90% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.66% 4.63% 0.28%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.82% 3.41% 1.66%
Unreported/Refused to Report Race and Ethnicity 16.60% 14.63% 16.57%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 50.00%
1 to 24 Hours 12.50%
More Than 24 Hours 37.50%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 12.50%
Vaccine confidence 50.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 50.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 0.00%
Average Percent of Health Center Visits Conducted Virtually 11.88%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 37.50%
Number of Mobile Van Sites 8
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 25.00%
Refer patients to another organization that provides monoclonal antibody therapies 87.50%
None 0.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 0.00%
Therapy administration/onsite logistics 0.00%
Other 0.00%
None 100.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021